Synageva BioPharma Corp (NASDAQ:GEVA)

Delayed Data
As of Apr 24
 +0.92 / +0.86%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Synageva BioPharma Corp have a median target of 113.00, with a high estimate of 125.00 and a low estimate of 88.00. The median estimate represents a +4.14% increase from the last price of 108.51.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in Synageva BioPharma Corp. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Apr 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 1.40%
Growthannually -27.52%


Growthquarterly 3.74%
Growthannually 32.88%
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account